DALLAS — Sept. 25, 2006 — Researchers at UT Southwestern Medical Center are seeking patients to participate in medical studies on blood pressure, type 2 diabetes and human papilloma virus. All clinical trials are approved by UT Southwestern's Institutional Review Board, which reviews them for benefits, risks, side effects and informed consent.
Blood pressure
UT Southwestern Medical Center is seeking healthy women who are planning on becoming pregnant in the near future. The study will investigate how blood pressure is controlled during pregnancy in healthy women. Participants will be watched before, during and immediately following their pregnancy. The study includes blood pressure monitoring, blood tests, head-up tilt and microneurography. Compensation is available. For more information, contact the Institute for Exercise and Environmental Medicine — a joint program between UT Southwestern and Presbyterian Hospital of Dallas — at 214-345-4654.
Type 2 diabetes
Researchers at UT Southwestern Medical Center are conducting a study of type 2 diabetes by investigating the use of a medication added to a participants' current dose of Actos or Avandia. Eligible participants must be between 18 and 77 years of age. Qualified participants will receive study-related medications (including current dose of Actos or Avandia), diet and activity counseling, physical exams, electrocardiogram and routine labs. For more information, please call 214-Diabetes (214-342-2383).
Human Papilloma Virus (HPV)
UT Southwestern Medical Center researchers are testing experimental medications and therapies for the treatment of cervical dysplasia, a pre-cancerous condition that can lead to cervical cancer if left untreated. The study involves an investigational gene therapy to see if it safely and effectively treats HPV cervical lesions. Eligible study candidates must be between the ages of 13 and 25 and have had an abnormal PAP test. Minors interested in participating must be accompanied by an adult and all study-related care will be provided at no charge. For more information, contact Diana Gossett at 214-648-3283.
More clinical trials
###
Media Contact: Katherine Morales
214-648-3404
e-mail: katherine.morales@utsouthwestern.edu
To automatically receive news releases from UT Southwestern via e-mail, subscribe at www.utsouthwestern.edu/receivenews
